According to researchers, blood-thinning drugs can help save COVID-19 patients' lives, The Telegraph reported.
Specialists at Royal Brompton Hospital's severe respiratory failure service have established a link between COVID-19 and clotting by using dual energy CT scans to take images of lung function in their most serious patients.
The scans show that all of those tested suffered a lack of blood flow, suggesting clotting within the small vessels in the lung.
The team treated and studied more than 150 of some of the UK's most critically ill patients, with the scans establishing that injury to the lungs was "a lot more apparent" among COVID sufferers than it would be among other patients suffering lung failure
Brijesh Patel, a senior intensivist at Royal Brompton and Imperial, said "I think it is important to introduce blood thinning agents that are associated with COVID, but you have to do it in the right way, otherwise you can cause harm."
The new findings mean that randomised clinical trials to test anticoagulant agents on COVID-19 patients are being fast-tracked as part of the UK Government's urgent research portfolio.
To read more NewsPoints articles, click here.